33 employees
Vivet Therapeutics is a biotechnology company developing gene therapy treatments for orphan diseases.
2016
$41M
from 3 investors over 3 rounds
Vivet Therapeutics raised $41M on May 4, 2017
Investors: Ysios Capital and HealthCap
Vivet Therapeutics raised undisclosed on April 1, 2017
Investors: Eurazeo